Feasibility Study to Evaluate the Observance Rehabilitation of Upper Limbs by Visual-motor Simulation Associated at Transcranial Direct Current Stimulation (tDCS) in Hemiparetic Patient Post-stroke

NCT ID: NCT03815266

Last Updated: 2023-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-20

Study Completion Date

2022-04-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although the mirror therapy is recognized as effective, its practice is difficult, especially with hemiplegic patients. It is difficult for them to understand, control the movements and carry out a double task with the two upper limbs. The implementation of a Computerized Mirror Therapy (CMT) with the Intensive Visual Simulation 3 (IVS3) device makes it possible to limit these problems by proposing pre-recorded sessions, not limited to the right or left hemi-space, and proposing a work on proximal motricity. Since the functional prognosis of the upper hemiplegic limb remains mostly unfavourable, a wide range of interventions should be proposed. There is currently a consensus to consider the use of transcranial Direct Current Stimulation (tDCS) stimulation in functional recovery after stroke as a method to enhance the effectiveness of training techniques. Although all motor therapies can theoretically benefit from increased effectiveness by the addition of transcranial Direct Current Stimulation (tDCS), Computerized Mirror Therapy (CMT) has a high potential for sensitivity to transcranial Direct Current Stimulation (tDCS) due to the intensity of the motor training of the upper limb applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to investigate the feasibility of a program combining Computerized Mirror Therapy (CMT) with dual- transcranial Direct Current Stimulation (tDCS) stimulation by evaluating observance to hemiparetic stroke patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with first ischemic or hemorrhagic stroke

Patient with first ischemic or hemorrhagic stroke will be included. They will have the following program Computerized Mirror Therapy (CMT) associated at transcranial Direct Current Stimulation (tDCS). This program will consist of 5 sessions per week for 4 weeks (20 minutes).

In more, they will have the following tests: Tolerance Assessment Questionnaire, Ashworth's scale, Frenchay arm test, Abilhand questionnaire, Fugl-Meyer test, and Goal Attainment Scaling (GAS).

Group Type EXPERIMENTAL

transcranial Direct Current Stimulation (tDCS)

Intervention Type DIAGNOSTIC_TEST

transcranial Direct Current Stimulation (tDCS) is device which consist in setting up an electrode on the skull of the patient to deliver the low intensity current.

Patient will have transcranial Direct Current Stimulation (tDCS) at each session and at the same time of Computerized Mirror Therapy (CMT).

Computerized Mirror Therapy (CMT)

Intervention Type DIAGNOSTIC_TEST

Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). Patient will have Computerized Mirror Therapy (CMT) at each session and at the same time of transcranial Direct Current Stimulation (tDCS).

Tolerance Assessment Questionnaire

Intervention Type DIAGNOSTIC_TEST

The Tolerance Assessment Questionnaire will be completed at the end of each session.

Ashworth's scale

Intervention Type DIAGNOSTIC_TEST

Ashworth's scale evaluates the resistance to stretching. This test will be completed before the start of the program, at the end of the program and one month after.

Frenchay arm test

Intervention Type DIAGNOSTIC_TEST

Frenchay arm test evaluates your abilities with the affected hand to perform several actions.

This test will be completed before the start of the program, at the end of the program and one month after.

Abilhand questionnaire

Intervention Type DIAGNOSTIC_TEST

Abilhand questionnaire evaluates your abilities to perform several activities in the daily life with your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.

Fugl-Meyer test

Intervention Type DIAGNOSTIC_TEST

Fugl-Meyer test evaluates your ability to perform different movements with all the joints of your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.

Goal Attainment Scaling (GAS)

Intervention Type DIAGNOSTIC_TEST

Goal Attainment Scaling (GAS) sets therapeutic goals with the patient before the start of the program.

These goals will be checked at the end of the program and one month after.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcranial Direct Current Stimulation (tDCS)

transcranial Direct Current Stimulation (tDCS) is device which consist in setting up an electrode on the skull of the patient to deliver the low intensity current.

Patient will have transcranial Direct Current Stimulation (tDCS) at each session and at the same time of Computerized Mirror Therapy (CMT).

Intervention Type DIAGNOSTIC_TEST

Computerized Mirror Therapy (CMT)

Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). Patient will have Computerized Mirror Therapy (CMT) at each session and at the same time of transcranial Direct Current Stimulation (tDCS).

Intervention Type DIAGNOSTIC_TEST

Tolerance Assessment Questionnaire

The Tolerance Assessment Questionnaire will be completed at the end of each session.

Intervention Type DIAGNOSTIC_TEST

Ashworth's scale

Ashworth's scale evaluates the resistance to stretching. This test will be completed before the start of the program, at the end of the program and one month after.

Intervention Type DIAGNOSTIC_TEST

Frenchay arm test

Frenchay arm test evaluates your abilities with the affected hand to perform several actions.

This test will be completed before the start of the program, at the end of the program and one month after.

Intervention Type DIAGNOSTIC_TEST

Abilhand questionnaire

Abilhand questionnaire evaluates your abilities to perform several activities in the daily life with your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.

Intervention Type DIAGNOSTIC_TEST

Fugl-Meyer test

Fugl-Meyer test evaluates your ability to perform different movements with all the joints of your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.

Intervention Type DIAGNOSTIC_TEST

Goal Attainment Scaling (GAS)

Goal Attainment Scaling (GAS) sets therapeutic goals with the patient before the start of the program.

These goals will be checked at the end of the program and one month after.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intensive Visual Simulation3 (IVS3)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with first ischemic or hemorrhagic stroke for less than one year, having not recidivated since then and responsible for initially complete left or right hemiplegia
* Modified Frenchay arm test score \<70 (/ 100)
* Without a neurological history other than stroke
* Having signed the written consent and affiliated or entitled to a social security scheme

Exclusion Criteria

* Patient with contraindications to transcranial Direct Current Stimulation (tDCS) or Transcranial Magnetic Stimulation (TMS) (brain metal implant, pacemaker, other implanted active medical device)
* Patient who didn't have cerebral Magnetic Resonance Imaging (MRI) imaging during their stroke
* With complete lesion of the primary motor cortex
* With alcohol / drug dependence
* With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignant disease, severe renal or pulmonary disease
* With a history of disabling associated disease
* With cerebellar syndrome
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pascal GIRAUX, PhD

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Saint-Etienne

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A01883-52

Identifier Type: OTHER

Identifier Source: secondary_id

1708098

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.